Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 1,441-1,452 of 1,909
Other study type icon
Not recruitingISRCTN34124141

Mobile technology health management for people with severe mental illness

This study is looking at whether a digital support tool can help people with severe mental illness. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
East London NHS Foundation Trust
Condition
Schizophrenia, Bipolarity
Drug study icon
Not recruitingISRCTN44497673

Testing an intervention to promote good oral health in people with severe mental illness

This study is looking at whether a mental health workshop can help people with severe mental illness. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.

In United Kingdom
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityOtherFrom 18 Years to 99 Years
Countries
United Kingdom
Sponsor
Sheffield Health and Social Care NHS Foundation Trust
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedEUCTR 2004-000751-42

A 26-week, International, Multicenter, Open-label Phase IIIb Study of the Safety and Tolerability of Quetiapine Fumarate (SEROQUEL™) Immediate-release Tablets in Daily Doses of 400 mg to 800 mg in ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Germany
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrugA study involving a medication or substance.
Countries
Germany
Sponsor
AstraZeneca AB
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedEUCTR 2009-016667-11

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as Adjunctive Therapy in Adults With Major D...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
France, Bulgaria, Spain
Sponsor
Cephalon, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2010-023623-26

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/day) as Adjunctive Therapy in Adults With Major Depressio...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria, Finland, Germany, ...
Sponsor
Cephalon, Inc.
Condition
Bipolarity, Depression
Drug study icon
TerminatedEUCTR 2010-018911-13

A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients with Schizophrenia...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrug
Countries
Bulgaria, Hungary, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedEUCTR 2005-001472-12

A Phase 3, Placebo-Controlled, Double-Blinded Continuation Trial Evaluating the Safety and Efficacy of Asenapine in Subjects Completing Trial A7501008 and Continuing Lithium or Valproic Acid/Divalp...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Bipolarity among several conditions.

BipolarityDrug
Countries
Czechia
Sponsor
N V Organon
Condition
Bipolarity
Drug study icon
CompletedEUCTR 2016-000756-98

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Fixed-Dose Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in Patients with Bipo...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Bulgaria
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Bulgaria, Croatia, Slovakia
Sponsor
Forest Laboratories LLC, an Allergan Affiliate
Condition
Bipolarity, Depression
Drug study icon
CompletedEUCTR 2015-003331-36

A Phase IV, Open-label, Non-randomized, Clinical Trial to Evaluate the Safety of self-administered ADASUVE(R) (Staccato loxapine for inhalation) in Agitated Patients outside the hospital setting

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Austria
Why is this study shown?

This study includes Bipolarity among several conditions.

Schizophrenia, BipolarityDrug
Countries
Austria, Norway
Sponsor
FERRER INTERNACIONAL SA
Condition
Schizophrenia, Bipolarity
Drug study icon
Active Not RecruitingEUCTR 2021-003676-13

A prospective randomized, double blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Vienna
Why is this study shown?

This study includes Bipolarity among several conditions.

Bipolarity, DepressionDrug
Countries
Austria
Sponsor
Medical University of Vienna
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.